<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-vaccines-08-00174">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nasveld</surname>
    <given-names>P.E.</given-names>
   </name>
   <name>
    <surname>Marjason</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Bennett</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Aaskov</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Elliott</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>McCarthy</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kanesa-Thasan</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Feroldi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Reid</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: Randomized double-blind phase II evaluation of safety and immunogenicity</article-title>
  <source>Hum. Vaccines</source>
  <year>2010</year>
  <volume>6</volume>
  <fpage>906</fpage>
  <lpage>914</lpage>
  <pub-id pub-id-type="doi">10.4161/hv.6.11.12854</pub-id>
 </element-citation>
</ref>
